Serena Hilman

794 total citations
20 papers, 223 citations indexed

About

Serena Hilman is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Serena Hilman has authored 20 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 8 papers in Oncology. Recurrent topics in Serena Hilman's work include Bladder and Urothelial Cancer Treatments (7 papers), Prostate Cancer Treatment and Research (6 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Serena Hilman is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Prostate Cancer Treatment and Research (6 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Serena Hilman collaborates with scholars based in United Kingdom, United States and Canada. Serena Hilman's co-authors include Simon J. Crabb, Satinder Jagdev, Syed A. Hussain, Robert J. Jones, Charlotte Ackerman, J. Frew, Daniel M. Berney, Andrew Stockdale, Mark Beresford and Santhanam Sundar and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Serena Hilman

19 papers receiving 222 citations

Peers

Serena Hilman
Regina Gironés Sarrió Spain
Alfonso Gómez de Liaño Spain
K. Nam United States
Urbano Anido Herranz Spain
Teresa Bonfill Spain
Kimiharu Takamatsu Japan
Gopal Bajaj United States
M. Ohori United States
Benjamin Miron United States
Ikko Tomisaki Japan
Regina Gironés Sarrió Spain
Serena Hilman
Citations per year, relative to Serena Hilman Serena Hilman (= 1×) peers Regina Gironés Sarrió

Countries citing papers authored by Serena Hilman

Since Specialization
Citations

This map shows the geographic impact of Serena Hilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Hilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Hilman more than expected).

Fields of papers citing papers by Serena Hilman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Hilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Hilman. The network helps show where Serena Hilman may publish in the future.

Co-authorship network of co-authors of Serena Hilman

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Hilman. A scholar is included among the top collaborators of Serena Hilman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Hilman. Serena Hilman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Robert J., Syed A. Hussain, Alison Birtle, et al.. (2022). A randomised, double blind, phase II clinical trial of maintenance cabozantinib following chemotherapy for metastatic urothelial carcinoma (mUC): Final analysis of the ATLANTIS cabozantinib comparison.. Journal of Clinical Oncology. 40(17_suppl). LBA4505–LBA4505. 5 indexed citations
2.
Thurtle, David, Valerie Jenkins, Alexandra L. J. Freeman, et al.. (2021). Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial. European Urology. 80(5). 661–669. 11 indexed citations
3.
Payne, Heather, Angus Robinson, Serena Hilman, et al.. (2021). A European, prospective, observational study of enzalutamide in patients with metastatic castration‐resistant prostate cancer: PREMISE. International Journal of Cancer. 150(5). 837–846. 13 indexed citations
4.
Brown, A. C., et al.. (2020). A study of the clinical, treatment planning and dosimetric feasibility of dose painting in external beam radiotherapy of prostate cancer. Physics and Imaging in Radiation Oncology. 15. 66–71. 5 indexed citations
5.
Payne, Heather, Angus Robinson, Serena Hilman, et al.. (2020). A European prospective observational study of enzalutamide (ENZA) in patients with metastatic castration-resistant prostate cancer (mCRPC): PREMISE. European Urology Open Science. 19. e883–e884. 1 indexed citations
6.
Rimmer, Y., Amy Law, Darren Leaning, et al.. (2019). National small cell bladder cancer audit: Results from 26 UK institutions. Annals of Oncology. 30. v373–v373. 1 indexed citations
7.
Hilman, Serena, et al.. (2019). One dose of immunotherapy leading to an exceptional and durable response in a patient with metastatic renal cell carcinoma. Oxford Medical Case Reports. 2019(12). 516–518. 1 indexed citations
8.
Hilman, Serena, et al.. (2018). A rare cutaneous adverse effect secondary to cabozantinib therapy. Oxford Medical Case Reports. 2018(12). omy105–omy105. 3 indexed citations
9.
Challapalli, Amarnath, et al.. (2018). Upfront docetaxel with androgen deprivation therapy in the elderly patient with metastatic hormone-naïve prostate cancer: Single institution experience.. Journal of Clinical Oncology. 36(6_suppl). 328–328. 2 indexed citations
10.
11.
Challapalli, Amarnath, Serena Hilman, Raj Persad, et al.. (2016). Radium-223 in metastatic castration resistant prostate cancer: Progression free survival and pain scores—Real-world single-institution experience.. Journal of Clinical Oncology. 34(2_suppl). 250–250.
12.
13.
Baumann, Brian C., Walter Bosch, Amit Bahl, et al.. (2016). Development and validation of contouring guidelines for post-cystectomy adjuvant radiation of bladder cancer.. Journal of Clinical Oncology. 34(2_suppl). 409–409. 5 indexed citations
14.
Wells, Tom, et al.. (2015). Improvements in the management of neutropenic sepsis: lessons learned from a district general hospital. Clinical Medicine. 15(6). 526–530. 7 indexed citations
15.
Challapalli, Amarnath, et al.. (2015). The Bristol Uro-oncology Complex Case Meeting: A New Model for Patient-centred Care. Clinical Oncology. 27(3). e8–e8. 2 indexed citations
16.
Powles, Thomas, Robert Huddart, Tony Elliott, et al.. (2015). A phase II/III, double-blind, randomized trial comparing maintenance lapatinib versus placebo after first line chemotherapy in HER1/2 positive metastatic bladder cancer patients.. Journal of Clinical Oncology. 33(15_suppl). 4505–4505. 16 indexed citations
17.
Christodouleas, John P., Brian C. Baumann, Walter Bosch, et al.. (2015). Development and Validation of Contouring Guidelines for Postcystectomy Adjuvant Radiation of Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). S24–S25. 1 indexed citations
18.
Tillett, Tania, Narottam Thanvi, Christopher Herbert, et al.. (2013). Thromboembolic events with cisplatin-based neoadjuvant chemotherapy for transitional cell carcinoma of urinary bladder.. Journal of Clinical Oncology. 31(6_suppl). 277–277. 3 indexed citations
19.
Hilman, Serena, S. Sothi, D. Peake, Johanna C. Andersson‐Assarsson, & J. M. Meis. (2009). Gastrointestinal stromal tumour with aKITexon 11 mutation presenting as a paratesticular mass. British Journal of Radiology. 82(977). e98–e101. 1 indexed citations
20.
Hilman, Serena, et al.. (2009). The use of treosulfan and gemcitabine in the treatment of platinum-resistant ovarian cancer. Oncology Letters. 1(1). 209–213. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Regina Gironés Sarrió Breakdown of academic impact, for papers by Alfonso Gómez de Liaño Breakdown of academic impact, for papers by K. Nam Breakdown of academic impact, for papers by Urbano Anido Herranz Breakdown of academic impact, for papers by Teresa Bonfill Breakdown of academic impact, for papers by Kimiharu Takamatsu Breakdown of academic impact, for papers by Gopal Bajaj Breakdown of academic impact, for papers by M. Ohori Breakdown of academic impact, for papers by Benjamin Miron Breakdown of academic impact, for papers by Ikko Tomisaki
Rankless by CCL
2026